PharmiWeb.com - Global Pharma News & Resources
19-Oct-2018

Global Personalized Medicine Market 2017-2024: Oncology is Estimated to Account for the Largest Market Segment Accounting for Approx 30% - ResearchAndMarkets.com

The "Global Personalized Medicine Market - Types, Technologies and Applications" report has been added to ResearchAndMarkets.com's offering.

Global Personalized Medicine market is expected to witness a robust CAGR of over 11% during the 2017-2024 analysis period and projected to touch US$194.4 billion by 2024 from an estimated US$92.4 billion in 2017. By application, Oncology is estimated the largest market accounting for about 30% throughout the analysis period.

Personalized medicine has a huge potential in leading the healthcare industry with drastic changes with a key focus on diseases understanding & management integrated with advanced analytics, patient data, customized medicines and other possibilities. Personalized Medicine will transform the entire pharmaceutical value chain, from early development to companies' go-to-market models, and the next five years will be a crucial window for pharmaceutical companies to capitalize on this promise.

Companies simply cannot sit on the sidelines during this period. Instead, they need to take risks and more actively engage with stakeholders throughout the healthcare ecosystem. However, there seems to be some challenges such as an unclear regulatory framework, insufficient access to high-quality data, data privacy issues and lack of standards.

Research Findings & Coverage

  • The global personalized medicine market is explored in this study with respect to product types, technologies and major applications
  • The exclusive analysis has been carried out for each product type, technology and major application of personalized in all major regions for the analysis period
  • Precision Medicine Enhanced through Artificial Intelligence and Blockchain
  • Personalized Cancer Therapy Gets a Boost from Patient-Derived Tumor Organoids
  • Future of Personalized Medicine Linked to Microbiomics
  • Key business trends focusing on product innovations/developments, M&As, JVs and other recent industry developments
  • Major companies profiled - 73
  • The industry guide includes the contact details for 115 companies

Key Topics Covered:

1. Introduction

2. Key Market Trends

3. Key Global Players

4. Key Business And Product Trends

5. Global Market Overview

6. North America

7. Europe

8. Asia-Pacific

9. South America

10. Rest of World

Companies Mentioned

  • Abbott Laboratories, Inc.
  • Abbott Molecular, Inc.
  • Bayer AG
  • Bayer Healthcare Pharmaceuticals
  • BG Medicine, Inc.
  • Bristol-Myers Squibb
  • Caliper Life Sciences, Inc.
  • Celera Corporation
  • Celgene Corporation
  • Eli Lilly and Company
  • GE Healthcare Ltd.
  • Genelex Corporation
  • Genentech, Inc.
  • Genewiz, Inc.
  • Genomic Health, Inc.
  • Genzyme Corporation
  • Glaxosmithkline Plc
  • Ingenuity Systems, Inc.
  • Intomics A/S
  • Johnson & Johnson
  • Medtronic Plc
  • Merck KGaA
  • Millennium Health, LLC.
  • Mitsubishi Tanabe Pharma Corporation
  • Mylan, N.V
  • Myriad Genetics, Inc.
  • Novartis AG
  • Novo Nordisk A/S
  • Pfizer, Inc.
  • Precision Biologics, Inc.
  • Promega Corporation
  • Qiagen N.V.
  • Siemens Healthcare GmbH
  • Takeda Pharmaceutical Company Limited

For more information about this report visit https://www.researchandmarkets.com/research/5ks53m/global?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181015005499/en/

Editor Details

Last Updated: 19-Oct-2018